Table 4 Outcome data
From: Prehospital administration of tranexamic acid in trauma patients
Tranexamic acid (TXA) group | Control group | p Value | |
|---|---|---|---|
ICU LOS, days, mean ± SD (n) | 10.7 ± 12.6 (258) | 9.2 ± 11.4 (258) | 0.03 |
Hospital LOS, days, mean ± SD (n) | 25.5 ± 23.2 (258) | 22.3 ± 25.4 (258) | 0.04 |
Thromboembolic event, n (%) | 4/71 (5.6) | 10/121 (8.3) | 0.58 |
Sepsis, n (%) | 4/67 (6.0) | 8/119 (6.7) | 1.00 |
Multiple organ failure, n (%) | 27/74 (36.5) | 35/121 (28.9) | 0.34 |
Time to death, days, mean ± SD (n) | 8.8 ± 13.4 (258) | 3.6 ± 4.9 (258) | 0.001 |
6-h mortality, n (%) | 5/258 (1.9) | 24/258 (9.3) | <0.001 |
12-h mortality, n (%) | 9/258 (3.5) | 28/258 (10.9) | 0.002 |
24-h mortality, n (%) | 15/258 (5.8) | 32/258 (12.4) | 0.01 |
30-day mortality, n (%) | 36/258 (14.0) | 42/258 (16.3) | 0.54 |
In-hospital mortality overall, n (%) | 38/258 (14.7) | 42/258 (16.3) | 0.72 |
Mortality prognosis in %, based on RISC 2 score (n) | 15.4 % (258) | 15.2 % (258) | 0.38 |